GO
Loading...

Endo Health Solutions Inc

More

  • July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. Covidien said it was indemnifying the manufacturer on certain claims.

  • *Focus turns to earnings season. NEW YORK, July 7- U.S. stocks dipped on Monday, retreating from last week's record levels as investors hesitated to make big bets before the start of earnings season. The Russell 2000 fell 1.8 percent, its biggest percentage drop since April 25.

  • NEW YORK, July 7- U.S. stocks fell on Monday, retreating from record levels as investors hesitated to make big bets before the dawn of earnings season. The Russell 2000 fell 1.5 percent, on track for its biggest percentage drop since May 20.

  • *Focus turns to earnings season. NEW YORK, July 7- U.S. stocks fell on Monday, pulling back from record levels as investors held off from making big plays before the start of earnings season.

  • July 7- Endo International Plc and BioDelivery Sciences International Inc said their experimental pain drug was found effective in a second late-stage trial, taking the drug a step closer to a marketing approval.

  • July 7- Endo International Plc and BioDelivery Sciences International Inc said their experimental pain drug was found effective in a second late-stage trial. Biodelivery, which entered into an agreement with Endo to develop the drug for the treatment of chronic pain in January 2012, will receive a $10 million milestone payment from Endo as part of the deal.

  • July 7- Endo International Plc and BioDelivery Sciences International Inc said their experimental pain drug was found effective in a late-stage trial. The painkiller, BEMA buprenorphine, was being tested against a placebo in patients with pain severe enough to require around-the-clock, long-term opioid treatment.

  • FDA asks for wider warning on testosterone products Friday, 20 Jun 2014 | 8:31 AM ET

    The FDA said that while testosterone products already carry a warning about the risk of clots related to a condition that sometimes occurs with testosterone treatment, the latest reports of clots were unrelated to that condition, called polycythemia.

  • June 3- The city of Chicago has filed a lawsuit against five large narcotics makers alleging they contributed to the country's prescription drug epidemic by deceptively promoting their painkillers.

  • March 6- Endo International Plc said the U.S. Food and Drug Administration approved its thrice-rejected testosterone replacement therapy, Aveed, to treat male hypogonadism.

  • Last month, the FDA issued an alert and said it was investigating the risk of stroke, heart attack and death in men taking testosterone drugs based on the recent publication of two studies that suggested increased cardiac risk. But the FDA said it had not concluded that testosterone does, in fact, increase heart problems.

  • Testosterone therapy is approved by the FDA for men who lack or have low testosterone in conjunction with an associated medical condition, such as a genetic failure of the testicles to produce testosterone.

  • WASHINGTON, Jan 31- The U.S. Food and Drug Administration said on Friday it is investigating the risk of stroke, heart attack and death in men taking prescription testosterone drugs.

  • Early movers: AOL, KORS, TMUS, CVS, AIG & more Tuesday, 5 Nov 2013 | 7:38 AM ET

    Some of the names on the move ahead of the open.

  • Check out which companies are making headlines after the bell Wednesday:

  • After-Hours Buzz: GPS, CRM, GRPN & More Thursday, 28 Feb 2013 | 3:40 PM ET

    Check out which companies are making headlines after the bell Thursday:

  • After-Hours Buzz: CSTR, PRGS & More Thursday, 3 Jan 2013 | 4:39 PM ET

    Check out which companies are making headlines after the bell Thursday:

  • After-Hours Buzz: Juniper, Boston Beer & More Wednesday, 12 Dec 2012 | 5:42 PM ET

    Check out which companies are making headlines after the bell Wednesday.

  • Shares of Samsung Electronics, which have surged almost 35 percent since the start of the year, closed at an all-time high on Thursday boosted by expectations that its smartphone business will continue to drive strong profit growth.

  • Here Are Small Cap Values: Gabelli Wednesday, 21 Nov 2012 | 1:39 PM ET

    With bigger companies looking to grow, many may look to acquire smaller firms. That’s one of the reasons Mario Gabelli, chairman of Gamco Investors, sees opportunity in small-cap equities.